Diabetologia. 2025 Feb 11. doi: 10.1007/s00125-025-06362-1. Online ahead of print. ABSTRACT AIMS/HYPOTHESIS: We aimed to assess whether continuous glucose monitor (CGM) metrics can accurately predict stage 3 type 1 diabetes diagnosis in those with islet autoantibodies (AAb). METHODS: Baseline CGM data were collected from participants with ≥1 positive AAb type…
